p97, also known as VCP, is an abundant and highly conserved AAA+ (ATPases associated with diverse cellular activities) ATPase that is crucial for maintaining cellular proteostasis. In addition to extracting proteins from membranes or molecular complexes for proteasomal degradation, p97 also plays key roles in lysosomal degradation through autophagy and endolysosomal sorting, membrane fusion, and the regulation of intracellular signaling, cell proliferation, and survival. These various cellular processes are propelled by the chemical energy released during ATP hydrolysis and are coordinated by p97's interactions with up to 40 cofactors, which direct it to specific subcellular sites and substrates for their processing and remodeling.
Numerous neurodegenerative diseases have been linked to p97 mutations, and overexpression of p97 in its wild-type is seen in many cancers. In addition, it has been demonstrated that p97 activity is necessary for the replication of a number of viruses, including influenza, poliovirus, herpes simplex virus, cytomegalovirus, and herpes simplex virus (HSV). These findings point to the possibility of using p97 targeting as a therapeutic strategy for neurodegeneration, cancer, and some infectious diseases.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V50940 | CB-5339 | 1863952-15-1 | CB-5339 is a novel inhibitor of p97 with an IC50 of less than 30 nM. |
|
V60010 | CB-5339 | 1863952-15-1 | CB-5339 is an orally bioactive p97 inhibitor (antagonist) with IC50 <30 nM and may be utilized in leukemia research. |
|
V1319 | DBeQ (JRF 12) | 177355-84-9 | DBeQ (JRF-12; JRF 12; JRF12) is a reversible and ATP-competitive p97 inhibitor with potential antineoplastic activity. |
|
V12068 | Eeyarestatin I | 412960-54-4 | Eeyarestatin I is a novel and potent ERAD (endoplasmic reticulum-associated protein degradation)inhibitor and protein translocation inhibitor with anticancer activity. |
|
V4007 | ML240 | 1346527-98-7 | ML240 is a novel potent p97 inhibitor which inhibits p97 ATPase with an IC50 value of 100 nM. |
|
V4006 | ML241 HCl | 2070015-13-1 | ML241 HCl is a novel and potent p97 inhibitor which inhibits p97 ATPase with an IC50 value of 100 nM. |
|
V1320 | MNS (NSC 170724, MDBN) | 1485-00-3 | MNS (NSC170724; NSC-170724; NSC 170724; 5-(2-Nitrovinyl)benzodioxole)) is a novel, potent and selective TKI-tyrosine kinase inhibitor with anti-platelet activity. |
|
V31538 | MSC1094308 | 2219320-08-6 | MSC1094308 (MSC-1094308) is a novel and potent allosteric inhibitor of the type II AAA ATPase. |
|
V1318 | NMS-873 | 1418013-75-8 | NMS-873 (also known as NMS 873, NMS873, p97 inhibitor) is a potent, allosteric and specific p97 inhibitor with potential antitumor activity. |
|
V41084 | NW 1028 | 2749599-78-6 | NW 1028 is a potent VCP/p97 inhibitor. |
|
V54752 | UPCDC30766 | 2152623-68-0 | UPCDC30766 is a potent allosteric inhibitor of p97 with IC50 of 12 nM. |
|
V35144 | VCP/p97 inhibitor-1 | 2630950-38-6 | VCP/p97 inhibitor-1 is a potent inhibitor of VCP/p97 (also known as Cdc48, CDC-. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
